Developmental and pathogenic mechanisms of basement membrane assembly

Current Pharmaceutical Design

Volumn 15, Issue 12, 2009, Pages 1277-1294

  Yurchenco, Peter D ^a   Patton, Bruce L ^b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Agrin; Alport's syndrome; Collagen; Dystroglycan; Epidermolysis bullosa; Extracellular matrix; Goodpasture syndrome; Integrin; Laminin; Muscular dystrophy; Nidogen; Peripheralneuropathy; Perlecan; Pierson syndrome

Indexed keywords

AGRIN; COLLAGEN TYPE 15; COLLAGEN TYPE 18; COLLAGEN TYPE 4; COLLAGEN TYPE 6; COLLAGEN TYPE 7; DYSTROGLYCAN; ENTACTIN; INTEGRIN; KALININ; LAMININ; LAMININ ALPHA2; MINIAGRIN; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ALPORT SYNDROME; BASEMENT MEMBRANE; BASEMENT MEMBRANE ASSEMBLY; CELLULAR DISTRIBUTION; CEREBROVASCULAR ACCIDENT; CYTOSKELETON; EPIDERMOLYSIS; EPIDERMOLYSIS BULLOSA; EXTRACELLULAR MATRIX; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC DISORDER; GOODPASTURE SYNDROME; HUMAN; LINKAGE ANALYSIS; MATRIX ATTACHMENT REGION; MUSCULAR DYSTROPHY; MUTATIONAL ANALYSIS; MYELINATION; NONHUMAN; PATHOGENESIS; PERIPHERAL NEUROPATHY; PIERSON SYNDROME; POLYMERIZATION; PORENCEPHALY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SARCOLEMMA; SCHWANN CELL; SIGNAL TRANSDUCTION;

AGRIN; ANIMALS; BASEMENT MEMBRANE; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LAMININ; MEMBRANE GLYCOPROTEINS; MYELIN SHEATH; NEUROMUSCULAR DISEASES; STROMAL CELLS;

EID: 65649130436     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209787846766     Document Type: Review

References (201)

1. Chan FL, Inoue S. Lamina lucida of basement membrane: An artifact. Microsc Res Tech 1994; 28: 48-59.
2. Chan FL, Inoue S, Leblond CP. The basement membranes of cryofixed or aldehyde-fixed, freeze-substituted tissues are composed of a lamina densa and do not contain a lamina lucida. Cell Tissue Res 1993; 273: 41-52.
3. Miosge N. The ultrastructural composition of basement membranes in vivo. Histol Histopathol 2001; 16: 1239-48.
4. Ruben GC, Yurchenco PD. High resolution platinum-carbon replication of freeze-dried basement membrane. Microsc.Res.Tech. 1994; 28: 13-28.
5. Yurchenco PD, Cheng YS, Ruben GC. Self-assembly of a high molecular weight basement membrane heparan sulfate proteoglycan into dimers and oligomers. J Biol Chem 1987; 262: 17668-76.
6. Yurchenco PD, Ruben GC. Type IV collagen lateral associations in the ehs tumor matrix. Comparison with amniotic and in vitro networks. Am J Pathol 1988; 132: 278-91.
7. Yurchenco PD, Ruben GC. Basement membrane structure in situ: Evidence for lateral associations in the type IV collagen network. J Cell Biol 1987; 105: 2559-68.
8. Yurchenco PD, Cheng YS, Colognato H. Laminin forms an independent network in basement membranes. J. Cell. Biol. 1992; 117: 1119-33.
9. Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, et al. A simplified laminin nomenclature. Matrix Biol 2005; 24: 326-32.
10. McKee KK, Harrison D, Capizzi S, Yurchenco PD. Role of laminin terminal globular domains in basement membrane assembly. J Biol Chem 2007; 282: 21437-47.
11. Smyth N, Vatansever HS, Murray P, Meyer M, Frie C, Paulsson M, et al. Absence of basement membranes after targeting the lamc1 gene results in embryonic lethality due to failure of endoderm differentiation. J Cell Biol 1999; 144: 151-60.
12. Miner JH, Li C, Mudd JL, Go G, Sutherland AE. Compositional and structural requirements for laminin and basement membranes during mouse embryo implantation and gastrulation. Development 2004; 131: 2247-56.
13. Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U. Collagen iv is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 2004; 131: 1619-28.
14. Yurchenco PD, Amenta PS, Patton BL. Basement membrane assembly, stability and activities observed through a developmental lens. Matrix Biol 2004; 22: 521-38.
15. Willem M, Miosge N, Halfter W, Smyth N, Jannetti I, Burghart E, et al. Specific ablation of the nidogen-binding site in the laminin gamma1 chain interferes with kidney and lung development. Development 2002; 129: 2711-22.
16. Yurchenco PD, Tsilibary EC, Charonis AS, Furthmayr H. Laminin polymerization in vitro. Evidence for a two-step assembly with domain specificity. J Biol Chem 1985; 260: 7636-44.
17. Garbe JH, Gohring W, Mann K, Timpl R, Sasaki T. Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin [alpha]3b and [alpha]5 chains. Biochem J 2002; 362: 213-21.
18. Yurchenco PD, Cheng YS. Self-assembly and calcium-binding sites in laminin. A three-arm interaction model. J Biol Chem 1993; 268: 17286-99.
19. Cheng YS, Champliaud MF, Burgeson RE, Marinkovich MP, Yurchenco PD. Self-assembly of laminin isoforms. J Biol Chem 1997; 272: 31525-32.
20. Paulsson M. The role of Ca2+ binding in the self-aggregation of laminin- nidogen complexes. J Biol Chem 1988; 263: 5425-30.
21. Yurchenco PD, Cheng YS, Schittny JC. Heparin modulation of laminin polymerization. J Biol Chem 1990; 265: 3981-91.
22. Odenthal U, Haehn S, Tunggal P, Merkl B, Schomburg D, Frie C, et al. Molecular analysis of laminin n-terminal domains mediating self-interactions. J Biol Chem 2004; 279: 44505-12.
23. Yurchenco PD, Wadsworth WG. Assembly and tissue functions of early embryonic laminins and netrins. Curr Opin Cell Biol 2004; 16: 572-9.
24. Schneiders FI, Maertens B, Bose K, Li Y, Brunken WJ, Paulsson M, et al. Binding of netrin-4 to laminin short arms regulates basement membrane assembly. J Biol Chem 2007; 282: 23750-8.
25. Tsiper MV, Yurchenco PD. Laminin assembles into separate basement membrane and fibrillar matrices in Schwann cells. J Cell Sci 2002; 115: 1005-15.
26. Li S, Harrison D, Carbonetto S, Fassler R, Smyth N, Edgar D, et al. Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation. J Cell Biol 2002; 157: 1279-90.
27. Li S, Liquari P, McKee KK, Harrison D, Patel R, Lee S, et al. Laminin-sulfatide binding initiates basement membrane assembly and enables receptor signaling in Schwann cells and fibroblasts. J Cell Biol 2005; 169: 179-89.
28. Nishiuchi R, Takagi J, Hayashi M, Ido H, Yagi Y, Sanzen N, et al. Ligand-binding specificities of laminin-binding integrins: A comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix Biol 2006
29. Ido H, Nakamura A, Kobayashi R, Ito S, Li S, Futaki S, et al. The requirement of the glutamic acid residue at the third position from the carboxyl termini of the laminin gamma chains in integrin binding by laminins. J Biol Chem 2007; 282: 11144-54.
30. Wizemann H, Garbe JH, Friedrich MV, Timpl R, Sasaki T, Hohenester E. Distinct requirements for heparin and alpha-dystroglycan binding revealed by structure-based mutagenesis of the laminin alpha2 LG4-5 domain pair. J Mol Biol 2003; 332: 635-42.
31. Harrison D, Hussain SA, Combs AC, Ervasti JM, Yurchenco PD, Hohenester E. Crystal structure and cell surface anchorage sites of laminin alpha 1 LG4-5. J Biol Chem 2007; 282: 11573-81.
32. Kikkawa Y, Virtanen I, Miner JH. Mesangial cells organize the glomerular capillaries by adhering to the g domain of laminin {alpha}5 in the glomerular basement membrane. J Cell Biol 2003; 161: 187-96.
33. Weir ML, Oppizzi ML, Henry MD, Onishi A, Campbell KP, Bissell MJ, et al. Dystroglycan loss disrupts polarity and {beta}-casein induction in mammary epithelial cells by perturbing laminin anchoring. J Cell Sci 2006; 119: 4047-58.
34. Moll J, Barzaghi P, Lin S, Bezakova G, Lochmuller H, Engvall E, et al. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature 2001; 413: 302-7.
35. Higginson JR, Winder SJ. Dystroglycan: A multifunctional adaptor protein. Biochem Soc Trans 2005; 33: 1254-5.
36. Roskelley CD, Bissell MJ. Dynamic reciprocity revisited: A continuous, bidirectional flow of information between cells and the extracellular matrix regulates mammary epithelial cell function. Biochem Cell Biol 1995; 73: 391-7.
37. Rybakova IN, Ervasti JM. Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association. J Biol Chem 1997; 272: 28771-8.
38. Rybakova IN, Patel JR, Davies KE, Yurchenco PD, Ervasti JM. Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle. Mol Biol Cell 2002; 13: 1512-21.
39. Rybakova IN, Patel JR, Ervasti JM. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J Cell Biol 2000; 150: 1209-14.
40. Warner LE, DelloRusso C, Crawford RW, Rybakova IN, Patel JR, Ervasti JM, et al. Expression of dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy. Hum Mol Genet 2002; 11: 1095-105.
41. Allikian MJ, Hack AA, Mewborn S, Mayer U, McNally EM. Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle. J Cell Sci 2004; 117: 3821-30.
42. Rooney JE, Welser JV, Dechert MA, Flintoff-Dye NL, Kaufman SJ, Burkin DJ. Severe muscular dystrophy in mice that lack dystrophin and {alpha}7 integrin. J Cell Sci 2006; 119(pt 11): 2185-95.
43. Guo C, Willem M, Werner A, Raivich G, Emerson M, Neyses L, et al. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. Hum Mol Genet 2006; 15: 989-98.
44. Wang HV, Chang LW, Brixius K, Wickstrom SA, Montanez E, Thievessen I, et al. Integrin-linked kinase stabilizes myotendinous junctions and protects muscle from stress-induced damage. J Cell Biol 2008; 180: 1037-49.
45. Brakebusch C, Fässler R. The integrin-actin connection, an eternal love affair. EMBO J 2003; 22: 2324-33.
46. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006; 126: 677-89.
47. Colognato H, Winkelmann DA, Yurchenco PD. Laminin polymerization induces a receptor-cytoskeleton network. J Cell Biol 1999; 145: 619-31.
48. Alcaraz J, Xu R, Mori H, Nelson CM, Mroue R, Spencer VA, et al. Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J 2008; 27: 2829-38.
49. Rousselle P, Keene DR, Ruggiero F, Champliaud MF, Rest M, Burgeson RE. Laminin 5 binds the NC-1 domain of type vii collagen. J Cell Biol 1997; 138: 719-28.
50. Ryan MC, Christiano AM, Engvall E, Wewer UM, Miner JH, Sanes JR, et al. The functions of laminins: Lessons from in vivo studies. Matrix Biol 1996; 15: 369-81.
51. Nakano A, Chao SC, Pulkkinen L, Murrell D, Bruckner-Tuderman L, Pfendner E, et al. Laminin 5 mutations in junctional epidermolysis bullosa: Molecular basis of Herlitz vs non-herlitz phenotypes. Hum Genet 2002; 110: 41-51.
52. Ryynanen M, Ryynanen J, Sollberg S, Iozzo RV, Knowlton RG, Uitto J. Genetic linkage of type VII collagen (col7a1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils. J Clin Invest 1992; 89: 974-80.
53. Georges-Labouesse E, Messaddeq N, Yehia G, Cadalbert L, Dierich A, Le Meur M. Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet 1996; 13: 370-3.
54. Dowling J, Yu QC, Fuchs E. Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol 1996; 134: 559-72.
55. van der Neut R, Krimpenfort P, Calafat J, Niessen CM, Sonnenberg A. Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice. Nat Genet 1996; 13: 366-9.
56. VanDeVoorde R, Witte D, Kogan J, Goebel J. Pierson syndrome: A novel cause of congenital nephrotic syndrome. Pediatrics 2006; 118: e501-5.
57. Wuhl E, Kogan J, Zurowska A, Matejas V, Vandevoorde RG, Aigner T, et al. Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndrome. Am J Med Genet A 2007; 143: 311-9.
58. Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanes JR, Merlie JP. The renal glomerulus of mice lacking s-laminin/laminin beta 2: Nephrosis despite molecular compensation by laminin beta 1. Nat Genet 1995; 10: 400-6.
59. Jarad G, Cunningham J, Shaw AS, Miner JH. Proteinuria precedes podocyte abnormalities inlamb2 mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest 2006; 116: 2272-9.
60. Miner JH, Go G, Cunningham J, Patton BL, Jarad G. Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: Implications for pierson syndrome. Development 2006; 133: 967-75.
61. Jimenez-Mallebrera C, Brown SC, Sewry CA, Muntoni F. Congenital muscular dystrophy: Molecular and cellular aspects. Cell Mol Life Sci 2005; 62: 809-23.
62. Sunada Y, Bernier SM, Utani A, Yamada Y, Campbell KP. Identification of a novel mutant transcript of laminin alpha 2 chain gene responsible for muscular dystrophy and dysmyelination in dy2j mice. Hum Mol Genet 1995; 4: 1055-61.
63. Miyagoe Y, Hanaoka K, Nonaka I, Hayasaka M, Nabeshima Y, Arahata K, et al. Laminin alpha2 chain-null mutant mice by targeted disruption of the lama2 gene: A new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 1997; 415: 33-9.
64. Kuang W, Xu H, Vilquin JT, Engvall E. Activation of the lama2 gene in muscle regeneration: Abortive regeneration in laminin alpha2-deficiency. Lab Invest 1999; 79: 1601-13.
65. Patton BL, Wang B, Tarumi YS, Seburn KL, Burgess RW. A single point mutation in the ln domain of lama2 causes muscular dystrophy and peripheral amyelination. J Cell Sci 2008; 121(pt 10): 1593-604.
66. Mayer U, Saher G, Fässler R, Bornemann A, Echtermeyer F, von der Mark H, et al. Absence of integrin alpha 7 causes a novel form of muscular dystrophy. Nat Genet 1997; 17: 318-23.
67. Straub V, Duclos F, Venzke DP, Lee JC, Cutshall S, Leveille CJ, et al. Molecular pathogenesis of muscle degeneration in the deltasarcoglycan-deficient hamster. Am J Pathol 1998; 153: 1623-30.
68. Schessl J, Zou Y, Bonnemann CG. Congenital muscular dystrophies and the extracellular matrix. Semin Pediatr Neurol 2006; 13: 80-9.
69. Barresi R, Michele DE, Kanagawa M, Harper HA, Dovico SA, Satz JS, et al. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med 2004; 10(7): 696-703.
70. Mayer U. Integrins: Redundant or important players in skeletal muscle? J Biol Chem 2003; 278: 14587-90.
71. Bloch RJ, Reed P, O'Neill A, Strong J, Williams M, Porter N, et al. Costameres mediate force transduction in healthy skeletal muscle and are altered in muscular dystrophies. J Muscle Res Cell Motil 2004; 25: 590-2.
72. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J.Cell.Biol. 1993; 122: 809-23.
73. Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve 2000; 23: 1456-71.
74. Michele DE, Campbell KP. Dystrophin-glycoprotein complex: Post-translational processing and dystroglycan function. J Biol Chem 2003; 278: 15457-60.
75. Gawlik K, Miyagoe-Suzuki Y, Ekblom P, Takeda S, Durbeej M. Laminin {alpha}1 chain reduces muscular dystrophy in laminin {alpha}2 chain deficient mice. Hum Mol Genet 2004; 13(16): 1775-84.
76. Gawlik KI, Li JY, Petersen A, Durbeej M. Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy. Hum Mol Genet 2006; 15: 2690-700.
77. Meinen S, Barzaghi P, Lin S, Lochmuller H, Ruegg MA. Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages. J Cell Biol 2007; 176: 979-93.
78. Muntoni F, Brockington M, Brown SC. Glycosylation eases muscular dystrophy. Nat Med 2004; 10: 676-7.
79. Kammerer RA, Schulthess T, Landwehr R, Schumacher B, Lustig A, Yurchenco PD, et al. Interaction of agrin with laminin requires a coiled-coil conformation of the agrin-binding site within the laminin gamma1 chain. EMBO J 1999; 18: 6762-70.
80. Bentzinger CF, Barzaghi P, Lin S, Ruegg MA. Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-{alpha}2-deficient mice. FASEB J 2005; 19: 934-42.
81. Eusebio A, Oliveri F, Barzaghi P, Ruegg MA. Expression of mouse agrin in normal, denervated and dystrophic muscle. Neuromuscul Disord 2003; 13: 408-15.
82. Guo LT, Zhang XU, Kuang W, Xu H, Liu LA, Vilquin JT, et al. Laminin alpha2 deficiency and muscular dystrophy; genotypephenotype correlation in mutant mice. Neuromuscul Disord 2003; 13: 207-15.
83. Qiao C, Li J, Zhu T, Draviam R, Watkins S, Ye X, et al. Amelioration of laminin-{alpha}2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin. Proc Natl Acad Sci USA 2005; 102: 11999-2004.
84. Gilbert JJ, Steinberg MC, Banker BQ. Ultrastructural alterations of the motor end plate in myotonic dystrophy of the mouse (dy2J/dy2J). J Neuropathol Exp Neurol 1973; 32: 345-64.
85. Law PK, Saito A, Fleischer S. Ultrastructural changes in muscle and motor end-plate of the dystrophic mouse. Exp Neurol 1983; 80: 361-82.
86. Yurchenco PD, Cheng YS, Campbell K, Li S. Loss of basement membrane, receptor and cytoskeletal lattices in a laminin-deficient muscular dystrophy. J Cell Sci 2004; 117: 735-42.
87. Colognato H, Yurchenco PD. The laminin alpha2 expressed by dystrophic dy(2J) mice is defective in its ability to form polymers. Curr Biol 1999; 9: 1327-30.
88. Chen YY, McDonald D, Cheng C, Magnowski B, Durand J, Zochodne DW. Axon and Schwann cell partnership during nerve regrowth. J Neuropathol Exp Neurol 2005; 64: 613-22.
89. Yang D, Bierman J, Tarumi YS, Zhong YP, Rangwala R, Proctor TM, et al. Coordinate control of axon defasciculation and myelination by laminin-2 and -8. J Cell Biol 2005; 168: 655-66.
90. Bradley WG, Jenkison M. Neural abnormalities in the dystrophic mouse. J Neurol Sci 1975; 25: 249-55.
91. Stirling CA. Abnormalities in Schwann cell sheaths in spinal nerve roots of dystrophic mice. J Anat 1975; 119: 169-80.
92. Stirling CA. Experimental myelination in dystrophic mice. J Physiol 1975; 245: 36P.
93. Madrid RE, Jaros E, Cullen MJ, Bradley WG. Genetically determined defect of Schwann cell basement membrane in dystrophic mouse. Nature 1975; 257: 319-21.
94. Patton BL, Miner JH, Chiu AY, Sanes JR. Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice. J Cell Biol 1997; 139: 1507-21.
95. Patton BL, Connoll AM, Martin PT, Cunningham JM, Mehta S, Pestronk A, et al. Distribution of ten laminin chains in dystrophic and regenerating muscles. Neuromuscul Disord 1999; 9: 423-33.
96. Bunge RP, Bunge MB, Eldridge CF. Linkage between axonal ensheathment and basal lamina production by Schwann cells. Annu Rev Neurosci 1986; 9: 305-28.
97. Obremski VJ, Johnson MI, Bunge MB. Fibroblasts are required for Schwann cell basal lamina deposition and ensheathment of unmyelinated sympathetic neurites in culture. J Neurocytol 1993; 22: 102-17.
98. Obremski VJ, Wood PM, Bunge MB. Fibroblasts promote Schwann cell basal lamina deposition and elongation in the absence of neurons in culture. Dev Biol 1993; 160: 119-34.
99. Obremski VJ, Bunge MB. Addition of purified basal lamina molecules enables Schwann cell ensheathment of sympathetic neurites in culture. Dev Biol 1995; 168: 124-37.
100. Wallquist W, Plantman S, Thams S, Thyboll J, Kortesmaa J, Lannergren J, et al. Impeded interaction between Schwann cells and axons in the absence of laminin alpha4. J Neurosci 2005; 25: 3692-700.
101. Feltri ML, Porta DG, Previtali SC, Nodari A, Migliavacca B, Cassetti A, et al. Conditional disruption of {beta}1 integrin in Schwann cells impedes interactions with axons. J Cell Biol 2002; 156: 199-210.
102. Yu WM, Feltri ML, Wrabetz L, Strickland S, Chen ZL. Schwann cell-specific ablation of laminin gamma1 causes apoptosis and prevents proliferation. J Neurosci 2005; 25: 4463-72.
103. Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, et al. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 2003; 38: 747-58.
104. Chernousov MA, Kaufman SJ, Stahl RC, Rothblum K, Carey DJ. Alpha7beta1 integrin is a receptor for laminin-2 on Schwann cells. Glia 2007; 55: 1134-44.
105. Previtali SC, Dina G, Nodari A, Fasolini M, Wrabetz L, Mayer U, et al. Schwann cells synthesize alpha7beta1 integrin which is dispensable for peripheral nerve development and myelination. Mol Cell Neurosci 2003; 23: 210-8.
106. Previtali SC, Nodari A, Taveggia C, Pardini C, Dina G, Villa A, et al. Expression of laminin receptors in Schwann cell differentiation: Evidence for distinct roles. J Neurosci 2003; 23: 5520-30.
107. Timpl R, Wiedemann H, van Delden V, Furthmayr H, Kuhn K. A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 1981; 120: 203-11.
108. Oberbaumer I, Wiedemann H, Timpl R, Kuhn K. Shape and assembly of type IV procollagen obtained from cell culture. EMBO J 1982; 1: 805-10.
109. Yurchenco PD, Furthmayr H. Self-assembly of basement membrane collagen. Biochemistry 1984; 23: 1839-50.
110. Glanville RW, Qian RQ, Siebold B, Risteli J, Kuhn K. Amino acid sequence of the n-terminal aggregation and cross-linking region (7S domain) of the alpha 1 (IV) chain of human basement membrane collagen. Eur J Biochem 1985; 152: 213-9.
111. Yurchenco PD, Furthmayr, H. Type IV collagen "7S" Tetramer formation: Aspects of kinetics and thermodynamics. Ann NY Acad Sci 1986; 460: 530-3.
112. Siebold B, Qian RA, Glanville RW, Hofmann H, Deutzmann R, Kuhn K. Construction of a model for the aggregation and crosslinking region (7S domain) of type IV collagen based upon an evaluation of the primary structure of the alpha 1 and alpha 2 chains in this region. Eur J Biochem 1987; 168: 569-75.
113. Bachinger HP, Fessler LI, Fessler JH. Mouse procollagen IV. Characterization and supramolecular association. J Biol Chem 1982; 257: 9796-803.
114. Duncan KG, Fessler LI, Bachinger HP, Fessler JH. Procollagen IV. Association to tetramers. J Biol Chem 1983; 258: 5869-77.
115. Weber S, Engel J, Wiedemann H, Glanville RW, Timpl R. Subunit structure and assembly of the globular domain of basement-membrane collagen type IV. Eur J Biochem 1984; 139: 401-10.
116. Sundaramoorthy M, Meiyappan M, Todd P, Hudson BG. Crystal structure of NC1 domains: Structural basis for type IV collagen assembly in basement membranes. J Biol Chem 2002; 22: 22.
117. Than ME, Henrich S, Huber R, Ries A, Mann K, Kuhn K, et al. The 1.9-Å crystal structure of the noncollagenous (NC1) domain of human placenta collagen IV shows stabilization via a novel type of covalent met-lys cross-link. Proc Natl Acad Sci USA 2002; 99: 6607-12.
118. Vanacore RM, Shanmugasundararaj S, Friedman DB, Bondar O, Hudson BG, Sundaramoorthy M. The alpha1alpha2 network of collagen IV. Reinforced stabilization of the noncollagenous domain-1 by noncovalent forces and the absence of met-lys cross-links. J Biol Chem 2004; 279: 44723-30.
119. Vanacore RM, Friedman DB, Ham AJ, Sundaramoorthy M, Hudson BG. Identification of s-hydroxylysyl-methionine as the covalent cross-link of the noncollagenous (NC1) hexamer of the alpha1alpha1alpha2 collagen IV network: A role for the posttranslational modification of lysine 211 to hydroxylysine 211 in hexamer assembly. J Biol Chem 2005; 280: 29300-10.
120. Gunwar S, Ballester F, Kalluri R, Timoneda J, Chonko AM, Edwards SJ, et al. Glomerular basement membrane. Identification of dimeric subunits of the noncollagenous domain (hexamer) of collagen IV and the Goodpasture antigen. J Biol Chem 1991; 266: 15318-24.
121. Netzer KO, Suzuki K, Itoh Y, Hudson BG, Khalifah RG. Comparative analysis of the noncollagenous NC1 domain of type IV collagen: Identification of structural features important for assembly, function, and pathogenesis. Protein Sci 1998; 7: 1340-51.
122. Boutaud A, Borza DB, Bondar O, Gunwar S, Netzer KO, Singh N, et al. Type IV collagen of the glomerular basement membrane: Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J Biol Chem 2000; 275(39): 30716-24.
123. Gunwar S, Ballester F, Noelken ME, Sado Y, Ninomiya Y, Hudson BG. Glomerular basement membrane. Identification of a novel disulfide-cross- linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of alport syndrome. J Biol Chem 1998; 273: 8767-75.
124. Miner JH, Sanes JR. Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): Implications for alport syndrome. J Cell Biol 1996; 135: 1403-13.
125. Guo XD, Johnson JJ, Kramer JM. Embryonic lethality caused by mutations in basement membrane collagen of C. elegans. Nature 1991; 349: 707-9.
126. Guo XD, Kramer JM. The two Caenorhabditis elegans basement membrane (type IV) collagen genes are located on separate chromosomes. J Biol Chem 1989; 264: 17574-82.
127. Huang CC, Hall DH, Hedgecock EM, Kao G, Karantza V, Vogel BE, et al. Laminin alpha subunits and their role in c. Elegans development. Development 2003; 130: 3343-58.
128. Nagai N, Hosokawa M, Itohara S, Adachi E, Matsushita T, Hosokawa N, et al. Embryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesis. J Cell Biol 2000; 150: 1499-506.
129. Koide T, Takahara Y, Asada S, Nagata K. Xaa-arg-gly triplets in the collagen triple helix are dominant binding sites for the molecular chaperone hsp47. J Biol Chem 2002; 277: 6178-82.
130. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 348: 2543-56.
131. Gould DB, Phalan FC, Breedveld GJ, van Mil SE, Smith RS, Schimenti JC, et al. Mutations in col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science 2005; 308: 1167-71.
132. Gould DB, Phalan FC, van Mil SE, Sundberg JP, Vahedi K, Massin P, et al. Role of col4a1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006; 354: 1489-96.
133. Durkin ME, Bartos BB, Liu SH, Phillips SL, Chung AE. Primary structure of the mouse laminin b2 chain and comparison with laminin B1. Biochemistry. 1988; 27: 5198-204.
134. Fox JW, Mayer U, Nischt R, Aumailley M, Reinhardt D, Wiedemann H, et al. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO. J. 1991; 10: 3137-46.
135. Mann K, Deutzmann R, Aumailley M, Timpl R, Raimondi L, Yamada Y, et al. Amino acid sequence of mouse nidogen, a multidomain basement membrane protein with binding activity for laminin, collagen IV and cells. EMBO J 1989; 8: 65-72.
136. Kohfeldt E, Sasaki T, Gohring W, Timpl R. Nidogen-2: A new basement membrane protein with diverse binding properties. J Mol Biol 1998; 282: 99-109.
137. Kimura N, Toyoshima T, Kojima T, Shimane M. Entactin-2: A new member of basement membrane protein with high homology to entactin/nidogen Exp Cell Res 1998; 241: 36-45.
138. Salmivirta K, Talts J, Olsson M, Sasaki T, Timpl R, Ekblom P. Binding of mouse nidogen-2 to basement membrane components and cells and its expression in embryonic and adult tissues suggest complementary functions of the two nidogens. Exp Cell Res 2002; 279: 188.
139. Takagi J, Yang Y, Liu JH, Wang JH, Springer TA. Complex between nidogen and laminin fragments reveals a paradigmatic betapropeller interface. Nature 2003; 424: 969-74.
140. Ries A, Gohring W, Fox JW, Timpl R, Sasaki T. Recombinant domains of mouse nidogen-1 and their binding to basement membrane proteins and monoclonal antibodies. Eur J Biochem 2001; 268: 5119-28.
141. Brown JC, Sasaki T, Gohring W, Yamada Y, Timpl R. The c-terminal domain v of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans. Eur J Biochem 1997; 250: 39-46.
142. Hopf M, Gohring W, Kohfeldt E, Yamada Y, Timpl R. Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin. Eur J Biochem 1999; 259: 917-25.
143. Ackley BD, Crew JR, Elamaa H, Pihlajaniemi T, Kuo CJ, Kramer JM. The NC1/ endostatin domain of Caenorhabditis elegans type xviii collagen affects cell migration and axon guidance. J Cell Biol 2001; 152: 1219-32.
144. Ackley BD, Kang SH, Crew JR, Suh C, Jin Y, Kramer JM. The basement membrane components nidogen and type XVIII collagen regulate organization of neuromuscular junctions in caenorhabditis elegans. J Neurosci 2003; 23: 3577-87.
145. Kim S, Wadsworth WG. Positioning of longitudinal nerves in C. elegans by nidogen. Science 2000; 288: 150-4.
146. Kang SH, Kramer JM. Nidogen is nonessential and not required for normal type IV collagen localization in caenorhabditis elegans. Mol Biol Cell 2000; 11: 3911-23.
147. Bader BL, Smyth N, Nedbal S, Miosge N, Baranowsky A, Mokkapati S, et al. Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice. Mol Cell Biol 2005; 25: 6846-56.
148. Burgess RW, Skarnes WC, Sanes JR. Agrin isoforms with distinct amino termini: Differential expression, localization, and function. J Cell Biol 2000; 151: 41-52.
149. Yamada H, Denzer AJ, Hori H, Tanaka T, Anderson LV, Fujita S, et al. Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J Biol Chem 1996; 271: 23418-23.
150. Denzer AJ, Brandenberger R, Gesemann M, Chiquet M, Ruegg MA. Agrin binds to the nerve-muscle basal lamina via laminin. J Cell Biol 1997; 137: 671-83.
151. Denzer AJ, Schulthess T, Fauser C, Schumacher B, Kammerer RA, Engel J, et al. Electron microscopic structure of agrin and mapping of its binding site in laminin-1. EMBO J 1998; 17: 335-43.
152. Gesemann M, Brancaccio A, Schumacher B, Ruegg MA. Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. J Biol Chem 1998; 273: 600-5.
153. Noonan DM, Fulle A, Valente P, Cai S, Horigan E, Sasaki M, et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin a chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 1991; 266: 22939-47.
154. Murdoch AD, Dodge GR, Cohen I, Tuan RS, Iozzo RV. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/ perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Biol Chem 1992; 267: 8544-57.
155. Kallunki P, Tryggvason K. Human basement membrane heparan sulfate proteoglycan core protein: A 467-Kd protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Cell Biol 1992; 116: 559-71.
156. Bix G, Fu J, Gonzalez EM, Macro L, Barker A, Campbell S, et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J Cell Biol 2004; 166: 97-109.
157. Mongiat M, Sweeney SM, San Antonio JD, Fu J, Iozzo RV. Endorepellin, a novel inhibitor of angiogenesis derived from the c terminus of perlecan. J Biol Chem 2003; 278: 4238-49.
158. Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, et al. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 1999; 147: 1109-22.
159. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat Genet 1999; 23: 354-8.
160. Arikawa-Hirasawa E, Le AH, Nishino I, Nonaka I, Ho NC, Francomano CA, et al. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am J Hum Genet 2002; 70: 5.
161. Nicole S, Davoine CS, Topaloglu H, Cattolico L, Barral D, Beighton P, et al. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 2000; 26: 480-3.
162. Peng HB, Xie H, Rossi SG, Rotundo RL. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol 1999; 145: 911-21.
163. Kvist AJ, Johnson AE, Morgelin M, Gustafsson E, Bengtsson E, Lindblom K, et al. Chondroitin sulfate perlecan enhances collagen fibril formation. Implications for perlecan chondrodysplasias. J Biol Chem 2006; 281: 33127-39.
164. Brittingham R, Uitto J, Fertala A. High-affinity binding of the NC1 domain of collagen vii to laminin 5 and collagen IV. Biochem Biophys Res Commun 2006; 343: 692-9.
165. Villone D, Fritsch A, Koch M, Bruckner-Tuderman L, Hansen U, Bruckner P. Supramolecular interactions in the dermo-epidermal junction zone: Anchoring fibril-collagen VII tightly binds to banded collagen fibrils. J Biol Chem 2008; 283: 24506-13.
166. Nakashima Y, Kariya Y, Yasuda C, Miyazaki K. Regulation of cell adhesion and type vii collagen binding by the beta3 chain short arm of laminin-5: Effect of its proteolytic cleavage. J Biochem 2005; 138: 539-52.
167. Dang N, Murrell DF. Mutation analysis and characterization of col7a1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol 2008; 17: 553-68.
168. Lampe AK, Bushby KM. Collagen VI related muscle disorders. J Med Genet 2005; 42: 673-85.
169. Myers JC, Amenta PS, Dion AS, Sciancalepore JP, Nagaswami C, Weisel JW, et al. The molecular structure of human tissue type XV presents a unique conformation among the collagens. Biochem J 2007
170. Eklund L, Piuhola J, Komulainen J, Sormunen R, Ongvarrasopone C, Fässler R, et al. Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. Proc Natl Acad Sci USA 2001; 98: 1194-9.
171. Marneros AG, Olsen BR. Physiological role of collagen XVIII and endostatin. FASEB J 2005; 19: 716-28.
172. Fukai N, Eklund L, Marneros AG, Oh SP, Keene DR, Tamarkin L, et al. Lack of collagen xviii/endostatin results in eye abnormalities. EMBO J 2002; 21: 1535-44.
173. Eble JA, Ries A, Lichy A, Mann K, Stanton H, Gavrilovic J, et al. The recognition sites of the integrins alpha1beta1 and alpha2beta1 within collagen IV are protected against gelatinase a attack in the native protein. J Biol Chem 1996; 271: 30964-70.
174. Colognato-Pyke H, O'Rear JJ, Yamada Y, Carbonetto S, Cheng YS, Yurchenco PD. Mapping of network-forming, heparin-binding, and alpha 1 beta 1 integrin-recognition sites within the alpha-chain short arm of laminin- 1. J Biol Chem 1995; 270: 9398-406.
175. Colognato H, MacCarrick M, O'Rear JJ, Yurchenco PD. The laminin alpha2-chain short arm mediates cell adhesion through both the alpha1beta1 and alpha2beta1 integrins. J Biol Chem 1997; 272: 29330-6.
176. Kortesmaa J, Yurchenco P, Tryggvason K. Recombinant laminin-8 (alpha 4beta 1gamma 1). Production, purification, and interactions with integrins. J Biol Chem 2000; 275: 14853-9.
177. Sasaki T, Timpl R. Domain IVa of laminin alpha5 chain is cell-adhesive and binds beta1 and alphavbeta3 integrins through arggly-asp. FEBS Lett 2001; 509: 181-5.
178. Pall EA, Bolton KM, Ervasti JM. Differential heparin inhibition of skeletal muscle alpha-dystroglycan binding to laminins. J Biol Chem 1996; 271: 3817-21.
179. Smirnov SP, McDearmon EL, Li S, Ervasti JM, Tryggvason K, Yurchenco PD. Contributions of the lg modules and furin processing to laminin-2 functions. J Biol Chem 2002; 277: 18928-37.
180. Ferletta M, Kikkawa Y, Yu H, Talts JF, Durbeej M, Sonnenberg A, et al. Opposing roles of integrin alpha6abeta1 and dystroglycan in laminin-mediated extracellular signal-regulated kinase activation. Mol Biol Cell 2003; 14: 2088-103.
181. Friedrich MV, Gohring W, Morgelin M, Brancaccio A, David G, Timpl R. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain v. J Mol Biol 1999; 294: 259-70.
182. Talts JF, Sasaki T, Miosge N, Gohring W, Mann K, Mayne R, et al. Structural and functional analysis of the recombinant g domain of the laminin {alpha}4 chain and its proteolytic processing in tissues. J Biol Chem 2000; 275(45): 35192-9.
183. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, et al. Post-translational disruption of dystroglycan ligand interactions in congenital muscular dystrophies. Nature 2002; 418: 417-21.
184. Yu H, Talts JF. Beta1 integrin and alpha-dystroglycan binding sites are localized to different laminin-G-domain-like (LG) modules within the laminin alpha5 chain G domain. Biochem J 2003; 371: 289-99.
185. Sakashita S, Engvall E, Ruoslahti E. Basement membrane glycoprotein laminin binds to heparin. FEBS Lett 1980; 116: 243-46.
186. Sallum CO, Kammerer RA, Alexandrescu AT. Thermodynamic and structural studies of carbohydrate binding by the agrin-G3 domain. Biochemistry 2007; 44(33): 9541-50.
187. Roberts DD, Rao CN, Magnani JL, Spitalnik SL, Liotta LA, Ginsburg V. Laminin binds specifically to sulfated glycolipids. Proc Natl Acad Sci USA 1985; 82: 1306-10.
188. Kalb E, Engel J. Binding and calcium-induced aggregation of laminin onto lipid bilayers. J Biol Chem 1991; 266: 19047-52.
189. Talts JF, Andac Z, Gorhing W, Brancaccio A, Timpl R. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J 1999; 18: 863-70.
190. Talts JF, Timpl R. Mutation of a basic sequence in the laminin alpha2LG3 module leads to a lack of proteolytic processing and has different effects on beta1 integrin-mediated cell adhesion and alpha-dystroglycan binding. FEBS Lett 1999; 458: 319-23.
191. Hopf M, Gohring W, Mann K, Timpl R. Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan. J Mol Biol 2001; 311: 529-41.
192. Hall H, Vorherr T, Schachner M. Characterization of a 21 amino acid peptide sequence of the laminin G2 domain that is involved in hnk-1 carbohydrate binding and cell adhesion. Glycobiology 1995; 5: 435-41.
193. Elola MT, Chiesa ME, Alberti AF, Mordoh J, Fink NE. Galectin-1 receptors in different cell types. J Biomed Sci 2005; 12: 13-29.
194. Shrivastava A, Radziejewski C, Campbell E, Kovac L, McGlynn M, Ryan TE, et al. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell 1997; 1: 25-34.
195. Meyer zum Gottesberge AM, Gross O, Becker-Lendzian U, Massing T, Vogel WF. Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1. Lab Invest 2008; 88: 27-37.
196. Gross O, Beirowski B, Harvey SJ, McFadden C, Chen D, Tam S, et al. DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria. Kidney Int 2004; 66: 102-11.
197. Lauer-Fields JL, Malkar NB, Richet G, Drauz K, Fields GB. Melanoma cell cd44 interaction with the alpha 1(IV)1263-1277 region from basement membrane collagen is modulated by ligand glycosylation. J Biol Chem 2003; 278: 14321-30.
198. Begovac PC, Hall DE, Shur BD. Laminin fragment E8 mediates PC12 cell neurite outgrowth by binding to cell surface beta 1,4 galactosyltransferase. J Cell Biol 1991; 113: 637-44.
199. Yurchenco PD, Smirnov S, Mathus T. In: Adams J, Ed. Methods in cell-matrix adhesion. 2002; Vol. 69, pp. 107-40.
200. Sung U, O'Rear JJ, Yurchenco PD. Cell and heparin binding in the distal long arm of laminin: Identification of active and cryptic sites with recombinant and hybrid glycoprotein. J Cell Biol 1993; 123: 1255-68.
201. Borza DB, Bondar O, Ninomiya Y, Sado Y, Naito I, Todd P, et al. The NC1 domain of collagen IV encodes a novel network composed of the alpha 1, alpha 2, alpha 5, and alpha 6 chains in smooth muscle basement membranes. J Biol Chem 2001; 276: 28532-40.